These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3578054)

  • 1. Hemodynamic, pharmacokinetic and clinical response to CI-930 in congestive heart failure due to ischemic or dilated cardiomyopathy.
    Jafri SM; Burlew BS; Goldberg AD; Olson S; Froelich JW; Goldstein S
    Am J Cardiol; 1987 May; 59(12):1126-30. PubMed ID: 3578054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure.
    Jafri SM; Burlew BS; Goldberg AD; Rogers A; Goldstein S
    Am J Cardiol; 1986 Feb; 57(4):254-9. PubMed ID: 3511661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Hagemeijer F; Brand HJ; van Mechelen R
    Am J Cardiol; 1989 Mar; 63(9):571-6. PubMed ID: 2919561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CI-930, a new cardiotonic and vasodilating agent: hemodynamic comparison to dobutamine and long-term clinical effects.
    Mancini D; Keren G; Sonnenblick EH; LeJemtel TH
    Am Heart J; 1988 Oct; 116(4):1008-16. PubMed ID: 3177174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic and hormonal effects of CI-930, a new phosphodiesterase inhibitor, in severe congestive heart failure.
    Murali S; Uretsky BF; Valdes AM; Kolesar JA; Reddy PS
    Am J Cardiol; 1987 Jun; 59(15):1356-60. PubMed ID: 3591691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
    Rauch B; Zimmermann R; Kapp M; Haass M; Von Molitor S; Smolarz A; Neumann FJ; Kübler W; Dietz R; Tillmanns H
    Clin Cardiol; 1991 May; 14(5):386-95. PubMed ID: 2049889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Miller AB; Conetta DA; Bass TA
    Am J Cardiol; 1985 May; 55(11):1359-62. PubMed ID: 3993570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Kiowski W; Erne P; Pfisterer M; Mueller J; Buehler FR; Burkart F
    Am J Cardiol; 1987 May; 59(12):1118-25. PubMed ID: 3578053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CI-914 in congestive heart failure due to coronary artery disease or idiopathic cardiomyopathy.
    Terris S; Bourdillon PD; Cheng D; Latts J; Olsen S; Nicklas J; Pitt B
    Am J Cardiol; 1986 Sep; 58(7):596-600. PubMed ID: 3751929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic performance during exercise in patients with severe chronic congestive heart failure before and after a single dose of pimobendan.
    Hagemeijer F
    J Cardiovasc Pharmacol; 1994 May; 23(5):741-6. PubMed ID: 7521456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
    Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Dickstein K; Manhenke C; Aarsland T; Køpp U; McNay J; Wiltse C
    Am J Cardiol; 1999 Jun; 83(12):1638-44. PubMed ID: 10392868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease.
    Cohn K; Selzer A; Kersh ES; Karpman LS; Goldschlager N
    Am J Cardiol; 1975 Apr; 35(4):461-8. PubMed ID: 1119395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute neurohormonal and hemodynamic response to a new peak III phosphodiesterase inhibitor (ICI 153,110) in patients with chronic heart failure.
    Jafri SM; Reddy BR; Budzinski D; Goldberg AD; Pilla A; Levine TB
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):360-6. PubMed ID: 1700205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemodynamic effects of endralazine: a new vasodilator for chronic refractory congestive heart failure.
    Quyyumi AA; Wagstaff D; Evans TR
    Am J Cardiol; 1983 May; 51(8):1353-7. PubMed ID: 6846162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B; Sebening H; Busch U; Lutilsky L
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
    Biddle TL; Benotti JR; Creager MA; Faxon DP; Firth BG; Fitzpatrick PG; Konstam MA; Krebs C; Walton L; Kershner RP
    Am J Cardiol; 1987 Jun; 59(15):1345-50. PubMed ID: 3591689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
    Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
    Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.